Literature DB >> 8384512

Phosphorylation, calpain proteolysis and tubulin binding of recombinant human tau isoforms.

J M Litersky1, C W Scott, G V Johnson.   

Abstract

In this study, the phosphorylation, calpain hydrolysis and tubulin binding of three recombinant human tau isoforms were examined. The three isoforms used in these studies were tau with three (T3) or four (T4) tandemly repeated tubulin binding domains located in the carboxy-terminal half of the molecule; and tau with four-tandem repeats and a 58-amino acid insert in the amino terminus (T4L). Both cAMP-dependent protein kinase (cAMP-PK) and Ca2+/calmodulin-dependent protein kinase II (CaMKII) readily phosphorylated the three human tau isoforms, although cAMP-PK phosphorylated them to a significantly greater extent than CaMKII. Phosphorylation of T3, T4 and T4L by cAMP-PK or CaMKII resulted in the slowed migration of the protein bands on sodium dodecyl sulfate-polyacrylamide gels and a shift of the isoelectric variants to more acidic positions on two-dimensional non-equilibrium pH gradient electrophoresis gels compared with controls. However, the phosphorylation-induced changes in the electrophoretic migration of the tau isoforms were unique for each kinase. Two-dimensional phosphopeptide maps and sequential phosphorylation experiments indicate that cAMP-PK phosphorylates sites in the human tau isoforms that are phosphorylated by CaMKII, as well as unique sites that are not phosphorylated by CaMKII. T3, T4 and T4L were hydrolyzed similarly by calpain; however, the calpain proteolysis of the recombinant tau isoforms was significantly faster than the proteolysis of human or bovine tau. Phosphorylation of the isoforms by either cAMP-PK or CaMKII did not alter the rate or extent of calpain proteolysis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384512     DOI: 10.1016/0006-8993(93)90349-r

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Phosphorylation of tau alters its association with the plasma membrane.

Authors:  F J Ekinci; T B Shea
Journal:  Cell Mol Neurobiol       Date:  2000-08       Impact factor: 5.046

2.  Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly.

Authors:  M A Utton; A Vandecandelaere; U Wagner; C H Reynolds; G M Gibb; C C Miller; P M Bayley; B H Anderton
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

3.  Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition.

Authors:  Kristine Cox; Benjamin Combs; Brenda Abdelmesih; Gerardo Morfini; Scott T Brady; Nicholas M Kanaan
Journal:  Neurobiol Aging       Date:  2016-07-29       Impact factor: 4.673

4.  Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP.

Authors:  L M Fleming; G V Johnson
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

Review 5.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

6.  Immunoblot analyses of the relative contributions of cysteine and aspartic proteases to neurofilament breakdown products following experimental brain injury in rats.

Authors:  R M Posmantur; X Zhao; A Kampfl; G L Clifton; R L Hayes
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

7.  Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356.

Authors:  J M Litersky; G V Johnson; R Jakes; M Goedert; M Lee; P Seubert
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

Review 8.  PEST sequences in calmodulin-binding proteins.

Authors:  J A Barnes; A V Gomes
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

Review 9.  Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases.

Authors:  Zhentao Zhang; Manling Xie; Keqiang Ye
Journal:  Expert Opin Ther Targets       Date:  2016-05-13       Impact factor: 6.902

10.  Glucose Regulates Microtubule Disassembly and the Dose of Insulin Secretion via Tau Phosphorylation.

Authors:  Kung-Hsien Ho; Xiaodun Yang; Anna B Osipovich; Over Cabrera; Mansuo L Hayashi; Mark A Magnuson; Guoqiang Gu; Irina Kaverina
Journal:  Diabetes       Date:  2020-06-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.